Purchase Order 75F40123P00405
- Not listed
- Impact Analytical Inc. has been awarded a $220,792 firm fixed price purchase order by the Department of Health and Human Services' Food and Drug Administration to conduct benzene screening of drug products. This small business set-aside contract supports the FDA's efforts to test over-the-counter drug products for contaminants and ensure their safety. Impact Analytical will screen samples for benzene at their laboratory in Silver Spring, Maryland, with work expected to be completed by...
- <p>This is a $170,575.00 firm fixed price purchase order contract awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Element Materials Technology Holding USA Inc. for the surveillance of non-sterile over-the-counter (OTC) drug products for objectionable microbial contamination. The contract does not have a set-aside designation and has an ultimate completion date of September 29, 2025. No further details about any larger contract vehicle are provided.</p>
- This is a firm-fixed price delivery order awarded by the Food and Drug Administration (FDA) to Enthalpy Analytical, LLC, a subsidiary of Montrose Environmental Group, Inc. The contract is for analysis and testing of tobacco products, e-cigarettes, and related emissions to support the FDA's regulatory oversight of these products. The contract has a ceiling value of $549,340.00 and a completion date of September 30, 2019. The contract was not set aside for any specific business type. Enthalpy...
- This is a firm fixed-price delivery order contract awarded by the Department of Health and Human Services Food and Drug Administration to Enthalpy Analytical, LLC, a for-profit limited liability company. The contract, valued at $1,491,885.78, is for monitoring baseline levels of select chemical constituents from multiple tobacco product categories in the U.S. market. Enthalpy Analytical, which has received multiple prior federal contract awards for analytical testing services related to...
- This is a delivery order contract awarded by the Department of Health and Human Services' Food and Drug Administration to Enthalpy Analytical, LLC, a limited liability company environmental services provider. The contract has a firm fixed price of $1,189,300.00 and a completion date of June 30, 2020. Enthalpy Analytical provides measurement, analytical, and environmental services to support the FDA's oversight and regulation of tobacco products, e-cigarettes, and related emissions. They have...
- This is a firm fixed-price delivery order contract awarded by the Department of Health and Human Services Food and Drug Administration to Enthalpy Analytical, LLC, a limited liability company environmental services provider. The contract, valued at $543,350.00, is for Phase II MATRIX SPECIFIC HPHC ANALYSIS services. Enthalpy Analytical, a subsidiary of Montrose Environmental Group, Inc., has previously provided analytical testing and laboratory services to the FDA to support oversight and...
- The Food and Drug Administration (FDA) awarded a $186.7K firm fixed-price purchase order to Element Materials Technology Holding USA Inc. on August 27, 2025, for screening sterile over-the-counter (OTC) monograph products for microbial contamination. The contract, with a performance location in Concord, California, is scheduled for completion by September 15, 2026, and carries no set-aside designation, indicating competitive procurement. Element Materials Technology, doing business as Element...
- This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Element Materials Technology ANN Arbor LLC, doing business as Avomeen Analytical Services. The contract, valued at $11,000.00, is for analytical characterization services. The services provided under this contract will involve laboratory analysis to characterize and quantify chemical constituents in materials, including leachate from electronic cigarette components and pharmaceuticals. The...
- The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price delivery order contract valued at twenty-five thousand four hundred dollars to Enthalpy Analytical, LLC for measuring menthol and mint flavor compounds quantities in tobacco products including cigarettes, cigarillos, and e-liquids. Performance will take place in Irvine, California with completion by August 15, 2020. Enthalpy Analytical, LLC is a subsidiary of Montrose Environmental Group, Inc....
- The U.S. Food and Drug Administration (FDA) awarded a $435,299.80 firm-fixed-price purchase order to Trajan Scientific Americas Inc., a foreign-owned small business manufacturer of scientific and medical devices, for the supply of a liquid chromatograph-gas chromatograph with flame ionization detector. This equipment will be used by the FDA for the analysis of mineral oil hydrocarbons (MOH) and sterols in fats and oils. The contract has a period of performance through September 10, 2025. This...
This is a $247,150.00 firm fixed price purchase order awarded by the Department of Health and Human Services' Food and Drug Administration to Impact Analytical Inc., a for-profit limited liability company. The contract is for the development of a validated analytical method and screening for diethylene glycol/ethylene glycol in over-the-counter children's cough syrup. The contract has a completion date of March 28, 2025. Impact Analytical Inc. is a full-service contract analytical laboratory that has provided analytical testing services, method development, and contaminant screening for over-the-counter drug products on behalf of the FDA in the past. They also hold an Indefinite Delivery Contract with the Department of the Navy's Strategic Systems Programs for sample testing services, which has a potential value of $250,000.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Development of a Validated Analytical Method and Screen for DEG/EG in OTC Childrens Cough Syrup. | 75F40123R00139 | Department of Health and Human Services Food and Drug Administration | Solicitation 1/1 | 8/23/23, 2:51 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | $0 | 5/13/24 | |
| Not listed | Not listed | $247.2k | 9/14/23 |